Law360, New York (September 30, 2010, 7:28 PM EDT) -- Merck & Co. Inc. vowed Thursday to fight a $4.6 million jury verdict against the drugmaker in a suit alleging that a defunct subsidiary of Schering-Plough Corp. — which is now owned by Merck — reported inflated prices for albuterol to the Massachusetts Medicaid program.
A jury in the U.S. District Court for the District of Massachusetts on Thursday awarded the state damages in the amount of $4.56 million following a three-week trial.
The long-running case was originally filed by Massachusetts in 2003. The drugs at...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.